Insights and Stories of Ludwig Burger

Jul. 25, 2023 at 8:44 am CDT

Reuters – Further deterioration in demand for glyphosate-based weed killers led Bayer BAYGn.DE to cut its full-year earnings outlook and announce a 2.5 billion euro ($2.8 billion USD) write-down on glyphosate-related assets. In an unscheduled statement late on Monday, the German drugs and pesticides maker said it was projecting 2023 […]

By Ludwig Burger, Thomas Escritt

Jan. 31, 2023 at 7:28 pm CST

Frankfurt | Reuters — A top-10 shareholder in Bayer on Tuesday called on the group’s supervisory board to replace CEO Werner Baumann quickly, adding to investor pressure to restore trust and revive the German drugmaker’s sagging share price. Despite recent improvements in the company’s agriculture business and drug development prospects, […]

By Ludwig Burger, Patricia Weiss

Aug. 4, 2022 at 2:46 pm CDT

Frankfurt | Reuters – Agriculture and pharmaceuticals company Bayer BAYGn.DE on Thursday lifted its 2022 earnings guidance on strong demand from farmers for its seeds and crop chemicals and higher sales of consumer health products. Bayer is now targeting earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for special […]

By Ludwig Burger, Patricia Weiss

Dec. 13, 2021 at 5:43 pm CST

Washington | Reuters — The U.S. Supreme Court on Monday asked President Joe Biden’s administration for its views on whether the justices should hear Bayer’s bid to dismiss claims by customers who contend its Roundup herbicide causes cancer, as the company seeks to avoid potentially billions of dollars in damages. […]

By lawrence-hurley, Ludwig Burger

Nov. 3, 2020 at 12:29 pm CST

Frankfurt | Reuters — Bayer is facing a double hit from a higher legal bill for claims relating to weedkiller Roundup as well as 9.25 billion euros (C$14.2 billion) in impairments on agriculture businesses, much of it related to its Monsanto deal. The company said the write-downs, driven by weaker […]

By Ludwig Burger, Patricia Weiss